Profile of ceritinib in the treatment of ALK+ metastatic non-small-cell lung cancer
Mark W Burns, Eric S Kim Wilmot Cancer Center, University of Rochester, Rochester, NY, USA Abstract: Lung cancer has become one of the leading causes of death in both men and women in the United States, with approximately 230,000 new cases and 160,000 deaths each year. Approximately 80% of lung can...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-05-01
|
| Series: | Lung Cancer : Targets and Therapy |
| Online Access: | http://www.dovepress.com/profile-of-ceritinib-in-the-treatment-of-alk-metastatic-non-small-cell-peer-reviewed-article-LCTT |